NCT01391962 2026-02-02
Sunitinib or Cediranib for Alveolar Soft Part Sarcoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
1 trialsPhase 2 × Sarcoma, Alveolar Soft Part × atropine sulfate-diphenoxylate hydrochloride drug combination × Clear all